Gayko Urte 4
4 · Summit Therapeutics Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Gayko Urte
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+25,000→ 25,000 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (25,000 underlying) - Award
Stock Option (right to buy)
2022-01-03$1.13/sh+42,553$48,085→ 67,553 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (42,553 underlying)
Footnotes (4)
- [F1]The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F2]Not applicable.
- [F3]The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F4]The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $48,000.